
    
      This study will evaluate the safety and tolerability following oral administration of
      multiple doses of BCI-838 in healthy male and female subjects. The pharmacokinetic profile of
      multiple oral doses of BCI-838 in healthy male and female subjects will also be assessed. In
      addition, the pharmacodynamic effects of BCI-838 on the central nervous system using
      quantitative electroencephalogram analysis will be studied.
    
  